Skip to main content
. 2021 Jun 5;5(3):625–634. doi: 10.1016/j.mayocpiqo.2021.04.001

Table 2.

Score Test Measure Frequencies Among Patients With Brain Tumors

Benign (n=207) Malignant (n=252)
General Anxiety Disorder-7, no. (%)
 Normal 127 (0.61) 133 (0.53)
 Mild anxiety 33 (0.16) 47 (0.19)
 Moderate anxiety 14 (0.07) 32 (0.13)
 Severe anxiety 8 (0.04) 15 (0.06)
Center for Epidemiologic Studies-Depression, no. (%)
 No indication of depression 134 (0.65) 144(0.57)
 Mild to moderate 30 (0.14) 38 (0.15)
 Possibility of major depression 16 (0.08) 34 (0.13)
Karnofsky Performance Status interpretation,a no. (%)
 Able to carry on normal activity and work, score of 80-100 169 (0.82) 193(0.76)
 Unable to work; able to care for most personal needs at home, score of 50-70 16 (0.08) 41 (0.16)
 Unable to care for self, score of 0-40 0 (0.0) 3 (0.01)
MD Anderson Symptom Inventory-Brain Tumor, no. (%)
 Mild 93 (0.43) 137 (0.54)
 Moderate 9 (0.04) 24 (0.09)
 Severe 5 (0.02) 15 (0.06)
a

Scores are typically in standard intervals of 10.